Director of Research Administration/Medical Writer Position

The Department of Internal Medicine, Division of Hematology/Oncology, and Simmons Cancer Center Kidney Cancer Program are recruiting for a Director of Research Administration (DRA) for the Kidney Cancer Program (KCP).Recognized with a Leaders in Clinical Excellence award, a finalist Healthcare Innovation award by D CEO and Dallas Innovates and with a Specialized Program of Research Excellence (SPORE) award by the National Cancer Institute, the KCP is a trailblazing program in the country.The successful applicant will join the faculty at UT Southwestern Medical Center, a premier medical center that ranks highly in healthcare research based on the Nature Index.ResponsibilitiesThe DRA will assist with:

• strategic development of research programs and new initiatives;
• grants and manuscript writing/submission;
• pre- and post-awards;
• progress reports;
• supervision and support of trainees;
• coordinating meetings and SPORE activities, including with advisory boards;
• intellectual property;
• material transfer agreements; and
• research compliance.

The DRA will join a team including a Program Coordinator/Financial Analyst and Director of Communications.RequirementsApplicants must have a Ph.D. in biology and be:

• well-organized,
• excellent writers,
• attentive to detail,
• goal-oriented,
• possess excellent communication, and
• time management skills.

Experience in research administration and grant management is encouraged but not essential.Qualified candidates should provide a cover letter, curriculum vitae, and arrange for three (3) letters of reference to be sent directly to Dr. James Brugarolas, Director of the Kidney Cancer Program, c/o Kathleen Worland, KCP Program Coordinator (KCPcoord@utsouthwestern.edu).Job: Physical presence required.Salary: $85,000 - $100,000/annual

About UTSW's Kidney Cancer Program The mission of the Kidney Cancer Program is to provide superb and compassionate care to all kidney cancer patients and their families, and to advance therapeutic developments through rigorous, innovative, high-impact research.